Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 535-542

  Chong, Chin Liew ^a,b   Huang, Shiu Feng ^a   Hu, Cheng Po ^f   Chen, Ya Ling ^a   Chou, Hsin Ying ^a   Chau, Gar Yang ^c   Shew, Jin Yuh ^d   Tsai, Yue Lin ^a   Chen, Chiung Tong ^a   Chang, Chungming ^a,b   Chen, Mong Liang ^a,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^f TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN UK114; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY; LIVER; LIVER NEOPLASMS; RIBONUCLEASES; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 41549128335     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0506     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-16.
3. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
4. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993;217:375-84.
5. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;83:1219-22.
6. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997;8:117-36.
7. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47-54.
8. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
9. Ceciliani F, Faotto L, Negri A, et al. The primary structure of UK114 tumor antigen. FEBS Lett 1996;393:147-50.
10. Levy-Favatier F, Cuisset L, Nedelec B, Tichonicky L, Kruh J, Delpech M. Characterization, purification and cDNA cloning of a rat perchloric-acid-soluble 23-kDa protein present only in liver and kidney. Eur J Biochem 1993;212:665-73.
11. Asagi K, Oka T, Arao K, et al. Purification, characterization and differentiation-dependent expression of a perchloric acid soluble protein from rat kidney. Nephron 1998;79:80-90.
12. Robello C, Dallagiovanna B, Engel JC, Gamarro F, Castanys S. A new member of YER057c family in Trypanosoma cruzi is adjacent to an ABC-transporter. Gene 1998;220:1-12.
13. Kim JM, Yoshikawa H, Shirahige K. A member of the YER057c/yjgf/ Uk114 family links isoleucine biosynthesis and intact mitochondria maintenance in Saccharomyces cerevisiae. Genes Cells 2001;6:507-17.
14. Leitner-Dagan Y, Ovadis M, Zuker A, et al. CHRD, a plant member of the evolutionarily conserved YjgF family, influences photosynthesis and chromoplastogenesis. Planta 2006;225:89-102.
15. Morishita R, Kawagoshi A, Sawasaki T, et al. Ribonuclease activity of rat liver perchloric acid-soluble protein, a potent inhibitor of protein synthesis. J Biol Chem 1999;274:20688-92.
16. Melloni E, Michetti M, Salamino F, Pontremoli S. Molecular and functional properties of a calpain activator protein specific for A-isoforms. J Biol Chem 1998;273:12827-31.
17. Schmiedeknecht G, Kerkhoff C, Orso E, et al. Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation. Eur J Biochem 1996;242:339-51.
18. Suzuki K, Nishida T, Matsumoto M, Kanouchi H, Kaneki K, Oka T. Purification, characterization and developmental expression of rat brain PSP protein. Biochim Biophys Acta 2001;1527:47-53.
19. Kaneki K, Matsumoto M, Suzuki K, Akuzawa M, Oka T. Purification, characterization and developmental expression of pig liver PSP. Comp Biochem Physiol B Biochem Mol Biol 2003;134:571-8.
20. Nordin H, Matsumoto M, Suzuki K, et al. Purification, characterization and developmental expression of chick (Gallus domesticus) liver PSP protein. Comp Biochem Physiol B Biochem Mol Biol 2001;128:135-43.
21. Kanouchi H, Oka T, Asagi K, Tachibana H, Yamada K. Expression and cellular distribution of perchloric acid-soluble protein is dependent on the cell-proliferating states of NRK-52E cells. Cell Mol Life Sci 2000;57:1103-8.
22. Kanouchi H, Tachibana H, Oka T, Yamada K. Recombinant expression of perchloric acid-soluble protein reduces cell proliferation. Cell Mol Life Sci 2001;58:1340-3.
23. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858-63.
24. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980;209:497-9.
25. Chang C, Lin Y, TW OL, et al. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol 1983;3:1133-7.
26. Oefinger PE, Bronson DL, Dreesman GR. Induction of hepatitis B surface antigen in human hepatoma-derived cell lines. J Gen Virol 1981;53:105-13.
27. Stevenson D, Lin JH, Tong MJ, Marshall GJ. Characteristics of a cell line (Tong/HCC) established from a human hepatocellular carcinoma. Hepatology 1987;7:1291-5.
28. Park JG, Lee JH, Kang MS, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer 1995;62:276-82.
29. Chou YC, Jeng KS, Chen ML, et al. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J Virol 2005;79:1813-23.
30. Kaneki K, Kanouchi H, Matsumoto M, Kawasaki Y, Akuzawa M, Oka T. Down regulation of a novel protein, PSP, in rat hepatoma cdRLh 84-beared tumor. J Vet Med Sci 2003;65:781-5.
31. Pozdniakovaite N, Popendikyte V. DNA methylation differences in human p14.5 gene promoter region in normal and proliferating cells. Dev Growth Differ 2005;47:493-9.
32. Morimitsu Y, Hsia CC, Kojiro M, Tabor E. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-α and its receptor in the different areas of tumor. Hum Pathol 1995;26:1126-32.
33. Brumm C, Schulze C, Charels K, Morohoshi T, Kloppel G. The significance of α-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology 1989;14:503-13.
34. Hsia CC, Di Bisceglie AM, Kleiner DE, Jr., Farshid M, Tabor E. RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus. J Med Virol 1994;44:67-73.
35. Saegusa M, Takano Y, Kishimoto H, Wakabayashi G, Nohga K, Okudaira M. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas - an enhanced immunohistochemical approach. J Cancer Res Clin Oncol 1993;119:737-44.
36. Huang LR, Coughtrie MW, Hsu HC. Down-regulation of dehydroepiandrosterone sulfotransferase gene in human hepatocellular carcinoma. Mol Cell Endocrinol 2005;231:87-94.